Evidence map›Paper›PMID 26151477›Full record

ArticleNature communications2015

SUMO and ubiquitin-dependent XPC exchange drives nucleotide excision repair.

Loes van Cuijk, Gijsbert J van Belle, Yasemin Turkyilmaz, Sara L Poulsen, Roel C Janssens, Arjan F Theil, Mariangela Sabatella, Hannes Lans, Niels Mailand, Adriaan B Houtsmuller and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 113 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Immune regulation by the SUMO family.Nature reviews. Immunology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. The small CRL4Nature communications · 2024
    Article
  9. Article
  10. SUMO and the DNA damage response.Biochemical Society transactions · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Loes van CuijkDepartment of Genetics, Cancer Genomics Netherlands Erasmus MC, Wytemaweg 80, Rotterdam 3015 CN, The Netherlands.
Gijsbert J van BelleDepartment of Pathology, Josephine Nefkens Institute, Erasmus MC, Dr Molewaterplein 50, Rotterdam 3015 GE, The Netherlands.
Yasemin TurkyilmazDepartment of Genetics, Cancer Genomics Netherlands Erasmus MC, Wytemaweg 80, Rotterdam 3015 CN, The Netherlands.
Sara L PoulsenUbiquitin Signaling Group, Protein Signaling Program, The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Blegdamsvej 3B, Copenhagen DK-2200, Denmark.
Roel C JanssensDepartment of Genetics, Cancer Genomics Netherlands Erasmus MC, Wytemaweg 80, Rotterdam 3015 CN, The Netherlands.
Arjan F TheilDepartment of Genetics, Cancer Genomics Netherlands Erasmus MC, Wytemaweg 80, Rotterdam 3015 CN, The Netherlands.
Mariangela SabatellaDepartment of Genetics, Cancer Genomics Netherlands Erasmus MC, Wytemaweg 80, Rotterdam 3015 CN, The Netherlands.
Hannes LansDepartment of Genetics, Cancer Genomics Netherlands Erasmus MC, Wytemaweg 80, Rotterdam 3015 CN, The Netherlands.ORCID 0000000344175358
Niels MailandUbiquitin Signaling Group, Protein Signaling Program, The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Blegdamsvej 3B, Copenhagen DK-2200, Denmark.ORCID 000000026623709X
Adriaan B HoutsmullerDepartment of Pathology, Josephine Nefkens Institute, Erasmus MC, Dr Molewaterplein 50, Rotterdam 3015 GE, The Netherlands.
Wim VermeulenDepartment of Genetics, Cancer Genomics Netherlands Erasmus MC, Wytemaweg 80, Rotterdam 3015 CN, The Netherlands.
Jurgen A MarteijnDepartment of Genetics, Cancer Genomics Netherlands Erasmus MC, Wytemaweg 80, Rotterdam 3015 CN, The Netherlands.
Cancer Genomics Centre · NLMeertens Institute · NLNovo Nordisk Foundation · DK

Funding

European Research Council 340988
6 · The paper itself

Abstract

XPC recognizes UV-induced DNA lesions and initiates their removal by nucleotide excision repair (NER). Damage recognition in NER is tightly controlled by ubiquitin and SUMO modifications. Recent studies have shown that the SUMO-targeted ubiquitin ligase RNF111 promotes K63-linked ubiquitylation of SUMOylated XPC after DNA damage. However, the exact regulatory function of these modifications in vivo remains elusive. Here we show that RNF111 is required for efficient repair of ultraviolet-induced DNA lesions. RNF111-mediated ubiquitylation promotes the release of XPC from damaged DNA after NER initiation, and is needed for stable incorporation of the NER endonucleases XPG and ERCC1/XPF. Our data suggest that RNF111, together with the CRL4(DDB2) ubiquitin ligase complex, is responsible for sequential XPC ubiquitylation, which regulates the recruitment and release of XPC and is crucial for efficient progression of the NER reaction, thereby providing an extra layer of quality control of NER.

Indexed as

Cell Line, TumorDNA-Binding ProteinsDNA DamageDNA Excision Repair Protein ERCC-5DNA RepairEndonucleasesGene Expression RegulationHumansNuclear ProteinsRNA, Small InterferingSUMO-1 ProteinTranscription FactorsUbiquitin-Protein LigasesDNA-Binding ProteinsDNA Excision Repair Protein ERCC-5EndonucleasesERCC1 protein, humanNuclear ProteinsRNA, Small InterferingRNF111 protein, humanSUMO-1 ProteinTranscription FactorsUbiquitin-Protein LigasesXPC protein, human

Identifiers

PMID26151477
PMCPMC4501428
OpenAlexW760082290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.